Judith Meijer
About
Judith Meijer is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry.
According to data from OpenAlex, Judith Meijer has authored 33 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Clinical Biochemistry. Recurrent topics in Judith Meijer's work include Biochemical and Molecular Research (23 papers), Metabolism and Genetic Disorders (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Judith Meijer is often cited by papers focused on Biochemical and Molecular Research (23 papers), Metabolism and Genetic Disorders (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Judith Meijer collaborates with scholars based in Netherlands, Sweden and Japan. Judith Meijer's co-authors include André B. P. Kuilenburg, Rutger Meinsma, Lida Zoetekouw, Doreen Dobritzsch, Raoul C. M. Hennekam, Dianne T. Keough, Luke W. Guddat, Johan Vande Voorde, Jan Balzarini and Lieve Naesens and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and International Journal of Cancer.
In The Last Decade
Judith Meijer
33 papers receiving 648 citations
Peers
Judith Meijer
Beáta Tóth Hungary
Marina Lanciotti Italy
Hirokazu Hirata Japan
Per Olaf Ekstrøm Norway
E Ennis United States
R. Pelka‐Fleischer Germany
Hella Kohlhof Germany
Gerard Minuesa United States
Tatiana Sedláčková Slovakia
B W Futscher United States
Citations per year, relative to Judith Meijer Judith Meijer (= 1×)
peers
Beáta Tóth
Countries citing papers authored by Judith Meijer
Since
Specialization
Citations
This map shows the geographic impact of Judith Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Meijer more than expected).
Fields of papers citing papers by Judith Meijer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Judith Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Meijer. The network helps show where Judith Meijer may publish in the future.
Co-authorship network of co-authors of Judith Meijer
This figure shows the co-authorship network connecting the top 25 collaborators of Judith Meijer. A scholar is included among the top collaborators of Judith Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Meijer. Judith Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kerst, J. Martijn, A.N.M. Wymenga, Maureen J.B. Aarts, et al.. (2024). Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO Open. 9(7). 103631–103631.
2.
Dobritzsch, Doreen, Judith Meijer, Rutger Meinsma, et al.. (2022). β-Ureidopropionase deficiency due to novel and rare UPB1 mutations affecting pre-mRNA splicing and protein structural integrity and catalytic activity. Molecular Genetics and Metabolism. 136(3). 177–185.
3.
Pérez‐Torras, Sandra, Britt I. Drögemöller, Maja Tarailo‐Graovac, et al.. (2019). Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1182–1191.
4.
Kuilenburg, André B. P., Judith Meijer, Rutger Meinsma, et al.. (2018). Dihydropyrimidine Dehydrogenase Deficiency: Homozygosity for an Extremely Rare Variant in DPYD due to Uniparental Isodisomy of Chromosome 1. JIMD Reports. 45. 65–69.
5.
Nakajima, Yoko, Judith Meijer, Doreen Dobritzsch, et al.. (2017). Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity. Molecular Genetics and Metabolism. 122(4). 216–222.
6.
Meulendijks, Didier, Linda M. Henricks, André B. P. Kuilenburg, et al.. (2016). Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines. Cancer Chemotherapy and Pharmacology. 78(4). 875–880.
7.
Kuilenburg, André B. P., Judith Meijer, Doreen Dobritzsch, et al.. (2016). Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(3). 721–730.
8.
Kuilenburg, André B. P., Henk‐Jan Guchelaar, Judith Meijer, et al.. (2015). Evaluation of an oral uracil loading test to identify DPD‐deficient patients using a limited sampling strategy. British Journal of Clinical Pharmacology. 81(3). 553–561.
9.
Kuilenburg, André B. P., Marie-Christine Étienne-Grimaldi, Abakar Mahamat, et al.. (2014). Frequent intragenic rearrangements of DPYD in colorectal tumours. The Pharmacogenomics Journal. 15(3). 211–218.
10.
Meinsma, Rutger, et al.. (2014). Dihydropyrimidine Dehydrogenase Deficiency in Two Malaysian Siblings with Abnormal MRI Findings. Molecular Syndromology. 5(6). 299–303.
11.
Naesens, Lieve, Luke W. Guddat, Dianne T. Keough, et al.. (2013). Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir). Molecular Pharmacology. 84(4). 615–629.
12.
Meijer, Judith, et al.. (2013). Identification of a Novel Synonymous Mutation in the Humanβ-Ureidopropionase GeneUPB1Affecting Pre-mRNA Splicing. Nucleosides Nucleotides & Nucleic Acids. 32(12). 639–645.
13.
Avril, Stefanie, Michaela Aubele, Tibor Schuster, et al.. (2013). Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. British Journal of Cancer. 109(9). 2347–2355.
14.
Kuilenburg, André B. P., Doreen Dobritzsch, Judith Meijer, et al.. (2012). ß-Ureidopropionase deficiency: Phenotype, genotype and protein structural consequences in 16 patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(7). 1096–1108.
15.
Kuilenburg, André B. P., Lida Zoetekouw, Judith Meijer, & TW Kuijpers. (2010). Determination of Adenosine Deaminase Activity in Dried Blood Spots by a Nonradiochemical Assay Using Reversed-Phase High-Performance Liquid Chromatography. Nucleosides Nucleotides & Nucleic Acids. 29(4-6). 461–465.
16.
Kuilenburg, André B. P., Judith Meijer, Adri N. Mul, et al.. (2010). Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity. Human Genetics. 128(5). 529–538.
17.
Kuilenburg, André B. P., Lida Zoetekouw, Judith Meijer, & TW Kuijpers. (2010). Identification of Purine Nucleoside Phosphorylase Deficiency in Dried Blood Spots by a Non-Radiochemical Assay Using Reversed-Phase High-Performance Liquid Chromatography. Nucleosides Nucleotides & Nucleic Acids. 29(4-6). 466–470.
18.
Kuilenburg, André B. P., Judith Meijer, Adri N. Mul, et al.. (2009). Analysis of severely affected patients with dihydropyrimidine dehydrogenase deficiency reveals large intragenic rearrangements of DPYD and a de novo interstitial deletion del(1)(p13.3p21.3). Human Genetics. 125(5-6). 581–590.
19.
Rampen, F.H.J. & Judith Meijer. (2009). Metastatic melanoma of the brain after spontaneous regression of the primary. Acta Neurologica Scandinavica. 72(2). 222–224.
20.
Kuilenburg, André B. P., Judith Meijer, Doreen Dobritzsch, et al.. (2008). Identification of Two Novel Mutations C79X and R235Q in the Dihydropyrimidine Dehydrogenase Gene in a Patient Presenting With Hematuria. Nucleosides Nucleotides & Nucleic Acids. 27(6-7). 809–815.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Beáta Tóth Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by Hirokazu Hirata Breakdown of academic impact, for papers by Per Olaf Ekstrøm Breakdown of academic impact, for papers by E Ennis Breakdown of academic impact, for papers by R. Pelka‐Fleischer Breakdown of academic impact, for papers by Hella Kohlhof Breakdown of academic impact, for papers by Gerard Minuesa Breakdown of academic impact, for papers by Tatiana Sedláčková Breakdown of academic impact, for papers by B W Futscher